Alan Colowick - Net Worth and Insider Trading

Alan Colowick Net Worth

The estimated net worth of Alan Colowick is at least $0 dollars as of 2024-11-07. Alan Colowick is the Director of Principia Biopharma Inc and owns about 0 shares of Principia Biopharma Inc (PRNB) stock worth over $0. Details can be seen in Alan Colowick's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Colowick has not made any transactions after 2020-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alan Colowick

To

Alan Colowick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan Colowick owns 8 companies in total, including Principia Biopharma Inc (PRNB) , Personalis Inc (PSNL) , and Dimension Therapeutics Inc (DMTX) among others .

Click here to see the complete history of Alan Colowick’s form 4 insider trades.

Insider Ownership Summary of Alan Colowick

Ticker Comapny Transaction Date Type of Owner
PRNB Principia Biopharma Inc 2020-09-28 director
PSNL Personalis Inc 2019-06-19 director
DMTX Dimension Therapeutics Inc 2017-11-07 director
LIMIT LIMIT 2017-06-14 director
LIMIT LIMIT 2006-10-16 President & Oncology
LIMIT LIMIT 2005-02-03 Chief Medical Officer
LIMIT LIMIT 2021-03-24 director
LIMIT LIMIT 2023-05-04 director

Alan Colowick Latest Holdings Summary

Alan Colowick currently owns a total of 1 stock. Alan Colowick owns 0 shares of Principia Biopharma Inc (PRNB) as of July 1, 2020, with a value of $0.

Latest Holdings of Alan Colowick

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PRNB Principia Biopharma Inc 2020-07-01 0 100.05 0

Holding Weightings of Alan Colowick


Alan Colowick Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan Colowick has made a total of 2 transactions in Principia Biopharma Inc (PRNB) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Principia Biopharma Inc is the sale of 7,500 shares on July 1, 2020, which brought Alan Colowick around $450,000.

Insider Trading History of Alan Colowick

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan Colowick Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alan Colowick Ownership Network

Ownership Network List of Alan Colowick

No Data

Ownership Network Relation of Alan Colowick

Insider Network Chart

Alan Colowick Owned Company Details

What does Principia Biopharma Inc do?

Who are the key executives at Principia Biopharma Inc?

Alan Colowick is the director of Principia Biopharma Inc. Other key executives at Principia Biopharma Inc include Chief Medical Officer Dolca Thomas , Chief Development Officer Stefani Wolff , and Chief Scientific Officer David M Goldstein .

Principia Biopharma Inc (PRNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Principia Biopharma Inc Insider Transactions

No Available Data

Alan Colowick Mailing Address

Above is the net worth, insider trading, and ownership report for Alan Colowick. You might contact Alan Colowick via mailing address: C/o Threshold Pharmaceuticals, Inc., 1300 Seaport Boulevard, 5th Floor, Redwood City Ca 94063.